000 01460 a2200457 4500
005 20250517155144.0
264 0 _c20180423
008 201804s 0 0 eng d
022 _a1476-5381
024 7 _a10.1111/bph.13892
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aScherma, Maria
245 0 0 _aCannabinoid CB
_h[electronic resource]
260 _bBritish journal of pharmacology
_cAug 2017
300 _a2682-2695 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnimals
650 0 4 _aAnorexia
_xblood
650 0 4 _aBody Weight
_xdrug effects
650 0 4 _aCannabinoid Receptor Agonists
_xpharmacology
650 0 4 _aCorticosterone
_xblood
650 0 4 _aCyclohexanols
_xpharmacology
650 0 4 _aDisease Models, Animal
650 0 4 _aDronabinol
_xpharmacology
650 0 4 _aEating
_xdrug effects
650 0 4 _aFemale
650 0 4 _aHyperkinesis
_xblood
650 0 4 _aLeptin
_xblood
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptor, Cannabinoid, CB1
650 0 4 _aReceptor, Cannabinoid, CB2
650 0 4 _aWeight Loss
_xdrug effects
700 1 _aSatta, Valentina
700 1 _aCollu, Roberto
700 1 _aBoi, Maria Francesca
700 1 _aUsai, Paolo
700 1 _aFratta, Walter
700 1 _aFadda, Paola
773 0 _tBritish journal of pharmacology
_gvol. 174
_gno. 16
_gp. 2682-2695
856 4 0 _uhttps://doi.org/10.1111/bph.13892
_zAvailable from publisher's website
999 _c27226311
_d27226311